Purchases and Sales Made in Q4 2021 in Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW) during Q4 2021. The information is specifically focused on institutions that hold shares of NEUROSENSE THERAPEUTICS LTD WT.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
425KNew |
$285K - $489K
|
425K
$85K
|
|
|
Feb 11, 2022
Q4 2021
|
Empery Asset Management, LP
New York, NY |
BUY
|
- |
160KNew |
$107K - $184K
|
160K
$32K
|
|
|
Feb 14, 2022
Q4 2021
|
Hudson Bay Capital Management LP
Greenwich, CT |
BUY
|
- |
150KNew |
$101K - $173K
|
150K
$30K
|
|
|
Feb 14, 2022
Q4 2021
|
Warberg Asset Management LLC
Winnetka, IL |
BUY
|
- |
66.6KNew |
$44.6K - $76.6K
|
66.6K
$13.3K
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
4.49KNew |
$3.01K - $5.16K
|
4.49K
$898
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|